IH
Insider selling
Ivan Hyep sold $808K of Bicara Therapeutics Inc. (BCAX) stock
Ivan Hyep, Chief Financial Officer of Bicara Therapeutics Inc. (BCAX), sold 28,000 shares of BCAX stock worth $808K, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 2 days before it was made public.
BCAX has moved -24.1% since the trade date, from $28.99 to $22.01 (Sep 21, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 2 days
- Price since
- -24.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More BCAX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.